Literature DB >> 30217372

Comparison of Outcomes and Cost of Endovascular Management Versus Surgical Bypass for the Management of Lower Extremities Peripheral Arterial Disease.

Rajkumar Doshi1, Khalid Hamid Changal2, Rajeev Gupta3, Jay Shah2, Krunalkumar Patel4, Rupak Desai5, Perwaiz Meraj4, Mubbasher Ameer Syed6, A Mujeeb Sheikh7.   

Abstract

The management of lower extremities peripheral arterial disease (LE-PAD) has always been debatable. We sought to explore in-hospital outcomes in hospitalizations that underwent endovascular or bypass surgery for LE-PAD from nation's largest, publicly available database. The National Inpatient Sample from 2012 to 2014 was queried to identify adult hospitalizations underwent endovascular management and bypass surgery for LE-PAD. Appropriate International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic and procedural codes were utilized to identify hospitalizations. A total of 89,256 hospitalizations were identified having endovascular management or bypass surgery for LE-PAD. More hospitalizations underwent endovascular intervention as compared with bypass surgery. Overall, hospitalizations for endovascular management had higher baseline co-morbidities and older age. A propensity score matched analysis was performed to compare in-hospital outcomes. After matching, 28,791 hospitalizations were included in each group. In-hospital mortality was significantly lower with endovascular intervention procedure as compared with surgical bypass group (1.5% vs 2.5%, p ≤0.001). All other secondary outcomes were noted lower with endovascular management except stroke and postprocedural infection. Taken together, these may account for higher discharges to home, lower length of stay, and less cost of hospitalizations associated with endovascular management. In conclusion, endovascular management is associated with lower in-hospital morbidity, mortality, length of stay, and cost when compared with bypass surgery in this study.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30217372     DOI: 10.1016/j.amjcard.2018.08.018

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Is There a Safety Concern for Drug-Coated Balloons in Peripheral Arterial Disease?

Authors:  Mohamed M Gad; Antonette K Karrthik; Ahmad A Mahmoud; Ahmed N Mahmoud
Journal:  Curr Cardiol Rep       Date:  2019-09-07       Impact factor: 2.931

2.  Atrial fibrillation in peripheral arterial disease with coexisting coronary artery disease and diabetes mellitus: An intricate association not to be missed!

Authors:  Sandeep Singh; Rupak Desai; Sara-Joan Pinto-Sietsma
Journal:  Clin Cardiol       Date:  2019-08-14       Impact factor: 2.882

3.  Epidemiological analysis of lower limb revascularization for peripheral arterial disease over 12 years on the public healthcare system in Brazil.

Authors:  Nelson Wolosker; Marcelo Fiorelli Alexandrino da Silva; Maria Fernanda Cassino Portugal; Nickolas Stabellini; Antônio Eduardo Zerati; Claudia Szlejf; Edson Amaro; Marcelo Passos Teivelis
Journal:  J Vasc Bras       Date:  2022-09-02

4.  Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.

Authors:  Federico Biscetti; Elisabetta Nardella; Maria Margherita Rando; Andrea Leonardo Cecchini; Flavia Angelini; Alessandro Cina; Roberto Iezzi; Marco Filipponi; Angelo Santoliquido; Dario Pitocco; Raffaele Landolfi; Andrea Flex
Journal:  Cardiovasc Diabetol       Date:  2020-10-07       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.